Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019046735) HEALTH PROMOTING COMPOSITION AND METHODS OF USE SUPPLEMENT RELATED APPLICATIONS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/046735 International Application No.: PCT/US2018/049117
Publication Date: 07.03.2019 International Filing Date: 31.08.2018
IPC:
A61P 3/02 (2006.01) ,A61P 29/00 (2006.01) ,A61P 3/06 (2006.01) ,A23L 33/17 (2016.01) ,A61K 31/198 (2006.01) ,A23L 33/15 (2016.01) ,A23K 20/174 (2016.01) ,A61K 38/39 (2006.01) ,A61K 31/166 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
02
Nutrients, e.g. vitamins, minerals
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29
Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
06
Antihyperlipidemics
[IPC code unknown for A23L 33/17]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
197
the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198
Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
[IPC code unknown for A23L 33/15][IPC code unknown for A23K 20/174]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
39
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
16
Amides, e.g. hydroxamic acids
165
having aromatic rings, e.g. colchicine, atenolol, progabide
166
having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
Applicants:
LONZA INC. [US/US]; 90 Boroline Road Allendale, New Jersey 07401, US
Inventors:
BELLAMINE, Aouatef; US
Agent:
CASSIDY, Timothy, A.; US
Priority Data:
62/552,47031.08.2017US
Title (EN) HEALTH PROMOTING COMPOSITION AND METHODS OF USE SUPPLEMENT RELATED APPLICATIONS
(FR) COMPOSITION FAVORISANT LA SANTÉ ET PROCÉDÉS D'UTILISATION D'APPLICATIONS ASSOCIÉES À UN COMPLÉMENT
Abstract:
(EN) The present disclosure is directed to a composition or nutritional supplement containing undenatured Type II collagen in combination with a Vitamin B compound or derivative thereof or any agent that can bind and/or activate the GPR109a receptor such as butyrates and dietary fibers and probiotics resulting to an increase in butyrates. The different dietary or nutraceutical agents are capable of synergistically working together to improve the health and well-being of a human or animal. For instance, the nutritional supplement can be used to treat joint discomfort and pain, improve immune, gastrointestinal and brain health, lowering cholesterol, or otherwise reducing inflammation in human and animal populations both at risk and actively presenting with such ailments.
(FR) La présente invention concerne une composition ou un complément nutritionnel contenant du collagène de Type II non dénaturé en combinaison avec un composé de vitamine B ou un dérivé de celui-ci ou tout agent qui peut se lier et/ou activer le récepteur GPR109a, tel que des butyrates et des fibres alimentaires et des probiotiques conduisant à une augmentation des butyrates. Les différents agents diététiques ou nutraceutiques sont aptes à fonctionner ensemble de manière synergique pour améliorer la santé et le bien-être d'un être humain ou d'un animal. Par exemple, le complément nutritionnel peut être utilisé pour traiter l'inconfort articulaire et la douleur articulaire, améliorer la santé immunitaire, gastro-intestinale et cérébrale, abaisser le taux de cholestérol ou autrement réduire l'inflammation dans des populations humaines et animales à la fois à risque de présenter de telles maladies et les présentant activement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)